Status:
COMPLETED
Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.
Lead Sponsor:
Sohag University
Conditions:
Lidocaine Spray
Eligibility:
MALE
20-50 years
Phase:
PHASE2
Brief Summary
This study aimed to appraise effectiveness and tolerability of lidocaine 5% spray in treatment of patients with premature ejaculation (PE). The current study has been designed as a randomized single-b...
Detailed Description
This study aimed to appraise effectiveness and tolerability of lidocaine 5% spray in treatment of patients with premature ejaculation (PE). The current study has been designed as a randomized single-b...
Eligibility Criteria
Inclusion
- Clinical diagnosis of lifelong premature ejaculation
Exclusion
- renal or liver diseases,
- diabetes mellitus,
- thyroid diseases,
- chronic prostatitis,
- neurological diseases
- allergic reactions to local anesthetics or alcohols.
- erectil dysfunction
Key Trial Info
Start Date :
April 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04062357
Start Date
April 20 2018
End Date
April 20 2019
Last Update
October 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Sohag University, Egypt
Sohag, Egypt, 82524